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ABSTRACT Telemonitoring of Parkinson’s Disease (PD) has attracted considerable research interest 
because of its potential to make a lasting, positive impact on the life of patients and their carers. Purpose-
built devices have been developed that record various signals which can be associated with average PD 
symptom severity, as quantified on standard clinical metrics such as the Unified Parkinson’s Disease Rating 
Scale (UPDRS). Speech signals are particularly promising in this regard, because they can be easily recorded 
without the use of expensive, dedicated hardware. Previous studies have demonstrated replication of UPDRS 
to within less than 2 points of a clinical raters’ assessment of symptom severity, using high-quality speech 
signals collected using dedicated telemonitoring hardware. Here, we investigate the potential of using the 
standard voice-over-GSM (2G) or UMTS (3G) cellular mobile telephone networks for PD telemonitoring, 
networks that, together, have greater than 5 billion subscribers worldwide. We test the robustness of this 
approach using a simulated noisy mobile communication network over which speech signals are transmitted, 
and approximately 6000 recordings from 42 PD subjects. We show that UPDRS can be estimated to within 
less than 3.5 points difference from the clinical raters’ assessment, which is clinically useful given that the 
inter-rater variability for UPDRS can be as high as 4-5 UPDRS points. This provides compelling evidence 
that the existing voice telephone network has potential towards facilitating inexpensive, mass-scale PD 
symptom telemonitoring applications. 
INDEX TERMS Decision support tool, Parkinson’s disease, nonlinear speech signal processing, 
telemedicine
I. INTRODUCTION 
Parkinson’s Disease (PD) is a chronic neurodegenerative 
disorder characterized by the progressive deterioration of 
motor function as well as the emergence of considerable non-
motor problems [1]. The PD incidence rate is approximately 
20/100,000 [2] and the prevalence rate exceeds 100/100,000 
[3]; moreover it is believed that an additional 20% of people 
with Parkinson’s (PWP) might be undiagnosed [4]. Early PD 
stages are mainly characterized by three hallmark symptoms: 
bradykinesia (slow and reduced amplitude of movement), 
rigidity (resistance to passive movement), and tremor (while 
at rest) [5].  
Medication and surgical intervention can alleviate some of 
the symptoms and improve quality of life for most PWP [6], 
although there is currently no known cure. To optimize 
treatment, PWP are typically followed up by expert clinical 
staff at relatively sparse (six to twelve month) intervals. 
Unfortunately, this contemporary triage of symptom 
management likely underestimates the true fluctuation of 
symptom severity. More regular PD symptom assessment 
would be of considerable benefit, for example, to optimize 




resources and the established assessment setting which 
requires the physical presence of PWP in the clinic.  
In current clinical practice, medical raters physically 
examine PWP and map symptom severity on appropriate 
clinical scales (metrics). The Unified Parkinson’s Disease 
Rating Scale (UPDRS) [7] is the most widely used clinical 
metric for quantifying PD impairment [8], and attempts to 
quantify the full breadth of possible motor (muscle), non-
motor PD symptoms, and complications of dopamine 
replacement therapies.  The motor symptoms are quantified 
using the motor-UPDRS, which is a subset and highly 
correlated with the total UPDRS  [9]. The motor-UPDRS 
ranges between 0 and 108, where 0 denotes healthy state, and 
108 severe disabilities, and the total-UPDRS lies in the range 
between 0 and 176. In addition to UPDRS, the Hoehn and 
Yahr (H&Y) scale is often used, and it is possible to infer 
H&Y from UPDRS [10], [11]. Other clinical scales are 
sometimes used in some medical centers, but for the 
purposes of this study we shall confine our analysis 
exclusively on UPDRS.  
Speech disorders, which are of particular interest in this 
study, may be amongst the earliest PD onset indicators [12], 
and are reported in the vast majority of PWP [13]. 
Furthermore, strong empirical evidence has emerged 
associating speech performance degradation and PD 
symptom severity [12-17]. Recent work has highlighted the 
intrinsic link between speech and specific motor 
functionality in PD in terms of freezing [18], sensory 
impairment [19], and determining genetically-determined 
PD (through Leucine-Rich Repeat Kinase 2, LRRK2 
mutations) [20]. 
Most PD studies rely on the use of expensive, purpose-
built specialized hardware to record signals which are 
characteristic of PD symptoms, e.g. [9], [21-24]. We have 
previously demonstrated the considerable potential of speech 
to replicate the clinical scale UPDRS [9], [24-26], using high 
quality speech signals collected with Intel Corporation’s At-
Home Testing Device (AHTD) [21]. This device collects 
high quality speech signals sampled at 24 kHz, following the 
established recommendation that a sampling frequency of at 
least 20 kHz should be used to extract clinically useful 
information [27].  
In this study, we investigate whether it is possible to 
accurately infer UPDRS using speech signals transmitted 
over the standard cellular mobile voice telephone network, 
using a detailed simulation of the entire digital 
communication process. The rationale for using the existing 
voice mobile phone network over specialized, purpose-built 
hardware such as the AHTD is that (a) the existing voice 
network reaches nearly 75% of the global population, (b) 
economies of scale and global market competition has 
brought the price of access down so that it is affordable to a 
majority of the global population, (c) mobile telephony 
allows freedom of movement for PWP, eliminating the need 
to carry additional equipment when leaving home. Thus, the 
standard phone network provides convenient means towards 
inexpensive and frequent PD severity assessments, 
facilitating monitoring and potentially assisting 
rehabilitation. Data-mining of speech signals obtained using 
the public telephone network to extract clinically useful 
information has recently shown promising results [28], [29], 
[30]. Similarly, Saenz-Lechon et al. [31] investigated the 
effect of different data transmission rates in automatic voice 
pathology detection, and concluded that compressing signals 
(down to at most 64 kbps) does not prevent accurate 
detection of vocal pathologies. 
We demonstrate that mobile phone technology could be 
useful in telemonitoring PD symptom severity, further 
endorsing previous findings that speech may offer a 
convenient framework for remote assessment [9], [24], [25]. 
II. DATA 
We use the voice data collected by Goetz et al. [21], 
described in detail in Tsanas et al. [9]. In brief, 52 subjects 
with idiopathic PD diagnosis up to five years from the time 
of the baseline clinical visit were recruited into a clinical trial 
to investigate the potential of the AHTD. All subjects gave 
written informed consent, and did not receive PD-related 
treatment for the six-month duration of the trial. They were 
asked to complete a range of tests weekly during a 
convenient, pre-specified time window (all tests can be 
completed in about 20-30 minutes). Sustained vowel /ah:/ 
phonations, where the subject is asked to sustain vowel 
phonation at a comfortable pitch for as long and as steadily 
as possible, were part of the test protocol. Here we focus 
exclusively on these sustained phonations. Subjects were 
diagnosed with PD if they had at least two of the three 
hallmark PD symptoms (bradykinesia, rigidity, tremor), 
without evidence of other forms of Parkinsonism. We did not 
apply any exclusion criteria related to specific PD symptoms 
(e.g. depression). We disregarded data from 10 participants 
– two that dropped out of the study early, and from eight 
additional PWP that did not complete at least 20 valid study 
sessions during the trial period. Therefore, in this study we 
analyze data from 42 PWP. 
Previously, we demonstrated that partitioning the data by 
gender is important in this application [9], [26], and hence 
males and females are studied separately here as well. The 
28 male subjects were 64.8±8.1 (mean ± standard deviation) 
years old, with a PD diagnosis 63.0±61.9 weeks since 
diagnosis at trial baseline. Their motor-UPDRS scores were: 
baseline 20.3±8.5, three months into the trial 21.9±8.7, six 
months into the trial 22.0±9.2, and total-UPDRS scores 
were: baseline 27.5±11.6, three months into the trial 
30.4±11.8, and six months into the trial 31.0±12.4. The 14 
female subjects were 63.6±11.6 years old, with a PD 
diagnosis 89.7±81.2 weeks since diagnosis at trial baseline. 
Their motor-UPDRS was: baseline 17.6±7.4, three months 
into the trial 21.2±10.5, six months into the trial 20.1±9.4, 




into the trial 27.4±12.1, and six months into the trial 
26.8±10.8. 
Six sustained vowel /ah:/ phonations were recorded each 
time the PD subject took the test: four at comfortable level 
of pitch and loudness, and two at twice the comfortable 
loudness (elicited with the instruction “twice as loud as the 
first time”). The signals were sampled at 24 kHz at 16 bit 
resolution. After initial processing to remove faulty 
phonations (e.g. patient coughing, failure to record 
phonation), we processed 4010 phonations for the male 
subjects, and 1865 phonations for the female subjects. 
Although the phonations were recorded weekly, the actual 
clinical assessments for motor-UPDRS and total-UPDRS 
were obtained at trial baseline, three months into the trial, 
and at six months into the trial. To obtain weekly UPDRS 
estimates to associate with the phonations we used piecewise 
linear interpolation going exactly through the measured 
baseline, three-month and six-month UPDRS assessments 
[9], [24], [25], [26], [32]. This assertion builds on strong 
empirical evidence suggesting that average symptom 
progression in early PD stages (up to about five years) is 
almost linear in non-medicated patients as observed in 
clinical metrics [33], [34]. The PWP in the AHTD trial were 
in early PD stages (up to five years from disease diagnosis) 
and remained non-medicated for the duration of the trial, 
aspects which justify the use of piecewise linear 
interpolation when filling in missing data. The tacit 
assumption is that PD symptom severity did not fluctuate 
wildly within the intervals where the clinical scores were 
obtained. Discretizing the response variable to transform a 
regression problem into a classification problem is well 
known in the machine learning literature, and often this step 
can lead to better prediction performance. We have found 
that in this application it is better to discretize the 
interpolated UPDRS scores and work with classifiers instead 
of regressors [9], [35]; hence both motor-UPDRS and total-
UPDRS were rounded to the closest integer value, giving rise 
to a multi-class classification setting. For another recent 
application from a different domain where this problem 
transformation was beneficial see [36]. 
For further details about the dataset and the AHTD data 
acquisition hardware, please refer to Tsanas et al. [9]. 
III. METHODS 
We re-iterate that the aim of the study is to investigate 
UPDRS estimation using speech signals transmitted over the 
standard cellular mobile voice telephone network. Given that 
the data available in the study has been collected using the high 
quality AHTD equipment we have used a digital 
communications simulation framework to study the distorted 
signals received through a hostile data transmission channel. 
The following section describes in detail the process used to 
simulate the data transmission and reception process of the 
raw speech signals so that they resemble realistic distorted 
signals we may expect to have in a practical cellular mobile 
telephony network. 
A. SIMULATION OF THE CELLULAR MOBILE 
TELEPHONY NETWORK 
Creating a realistic simulation of the cellular voice 
telephony network requires the following steps: (a) encoding 
the AHTD speech signals into bit-streams for transmission, 
(b) simulating the transmitter, radio channel, and receiver, 
and (c) decoding the transmitted bit-streams back into 
intelligible speech recordings. This application requires only 
one way (simplex) communication; PWP call into an 
automated voice messaging service and leave sustained 
vowel phonations. Predictions of symptom severity are 
extracted from these voice messages and clinical personnel 
suggest the appropriate course of action offline as a result of 
the estimated UPDRS. Moreover, the sustained vowel 
phonations need only be a few seconds long, that is, 
considerably shorter in duration than most telephone 
conversations.  
Fig. 1 presents the schematic diagram of the 
communication system used in this study. The main 
components of a digital communication system are the 
transmitter, the channel (physical medium connecting the 
transmitter and the receiver), and the receiver. The 
transmitter aims to assist the receiver to correctly recover the 
speech signal which may be distorted by the channel. We 
follow closely the studies of Tsanas [37], Ampeliotis and 
 
 
Fig. 1.  Schematic diagram of the digital communication process. ISI 





Berberidis [38], and Tuchler et al. [39] for the practical 
implementation. We summarize the data communications 
process in the Supplementary Material under section 1.1 
‘Overview of the data communication process’, and refer 
readers to specialized monographs for further background 
[40], [41].  
B. METHODOLOGY TO ANALYZE THE SPEECH 
SIGNALS RECOVERED AT THE RECEIVER 
We followed three steps to process the recovered 
phonations and extract clinically useful information: (a) 
feature extraction, where we applied speech signal 
processing algorithms to characterize the phonations and 
extract characteristic patterns (features), (b) feature 
selection, where a parsimonious (small, information-rich) 
subset of the originally computed features is selected in order 
to provide maximally useful information for predicting 
UPDRS, and (c) feature mapping, where a standard 
supervised learning algorithm was used to determine a 
functional form associating the selected feature subset with 
the clinical outcome (UPDRS). The rationale behind this 
methodology is that characteristic acoustic patterns in PWP’s 
voice are indicative of UPDRS. Although confounding 
factors may affect vocal performance (such as the subject’s 
emotional state, some pathological condition not related to 
PD, organic vocal pathology independent of PD, or 
pathologies due to tobacco abuse), it is unlikely these 
contaminate more than a handful of the approximately 6000 
recordings used here. We assumed that potential 
confounding factors do not dominate PWP’s voices to the 
extent that the extracted dysphonia measures do not provide 
clinically useful information for estimating UPDRS. 
Before characterizing the phonations by extracting 
dysphonia measures, we removed the vowel onset and offset 
choosing the three seconds in the middle of the phonation to 
simplify computational processing. The resulting three 
second signal was subsequently normalized to facilitate 
comparisons across recordings. 
Feature extraction 
We applied the dysphonia measures rigorously defined in 
Tsanas et al. [9] to the speech signals recovered at the 
receiver. We refer to that paper for detailed description of the 
concepts and rationale behind each algorithm. The 
MATLAB source code to compute these features is available 
on the first author’s website (https://www.darth-
group.com/software). Here, we briefly describe the most 
important families of dysphonia measures used in this and 
other studies. 
Some of the most widely used dysphonia measures are 
jitter and shimmer [27], [42]. They seek to capture the 
physiological observation that the vocal fold vibration 
pattern is nearly periodic in healthy voices, whilst it is 
disturbed in pathological voices [42]. Jitter characterizes 
deviations in fundamental frequency (F0), whereas shimmer 
characterizes deviations in amplitude. There is no unique 
definition of those dysphonia measures, and we investigated 
many jitter and shimmer variants [15] which are algorithmic 
variations of the same underlying concept. Quantifying vocal 
fold departure from near periodicity has inspired the 
development of the Recurrence Period Density Entropy 
(RPDE) [43], the Pitch Period Entropy (PPE) [44], the 
Glottal Quotient (GQ) [9], and F0-related measures [9]. GQ 
can be seen as an improved jitter-like family of measures, but 
working directly with vocal fold cycles instead of pre-
specified segments (e.g. 10 ms) of the speech signal. RPDE 
expresses the uncertainty in vocal fold cycle duration. PPE 
quantifies the impaired control of F0 in sustained phonations, 
taking into account normal vibrato. The F0-related measures 
include statistical summaries of F0 distributions, and F0 
differences compared to average age- and gender-matched 
healthy controls in the population. 
The second group of dysphonia measures characterize 
Signal to Noise Ratio (SNR)-like quantities. The 
physiological motivation for this group is that incomplete 
vocal fold closure leads to the creation of aerodynamic 
vortices which result in increased acoustic noise. Harmonic 
to Noise Ratio (HNR) [42], Detrended Fluctuation Analysis 
(DFA) [43], Glottal to Noise Excitation (GNE) [45], Vocal 
Fold Excitation Ratio (VFER) [9], and Empirical Mode 
Decomposition Excitation Ratio (EMD-ER) [9] are typical 
examples. GNE and VFER analyze the frequency ranges of 
the signal in bands of 500 Hz. Empirically, we found that 
frequencies below 2.5 kHz can be treated as ‘signal’, and 
everything above 2.5 kHz can be treated as ‘noise’ [9], [35] 
to define SNR measures using energy, nonlinear energy 
(Teager-Kaiser energy operator) and entropy concepts. 
EMD-ER is similarly motivated: the Hilbert-Huang 
transform [46] decomposes the original signal into its 
constituent components in decreasing order of contributing 
frequency. Then, the top (high frequency) components are 
taken to constitute noise, and the lower frequency 
components to constitute signal, to obtain SNR-like 
measures. 
Lastly, Mel Frequency Cepstral Coefficients (MFCC) 
have been traditionally used in speaker recognition 
applications, but also appear promising in biomedical speech 
signal processing contexts [9], [35], [47], [48]. Although the 
participants in this study were asked to sustain a vowel 
(hence theoretically the vocal folds have a steady oscillating 
pattern and the vocal tract remains completely steady), it is 
reasonable to argue that the articulators will exhibit some 
perturbation (similarly to the fact that the vocal folds will not 
vibrate with perfect periodicity, even for healthy controls 
when sustaining a vowel [27]). The MFCCs collectively 
characterize the short-term power spectrum of a speech 
signal on the nonlinear (Mel) scale, which approximates the 
human auditory system's response more closely than the 
linearly-spaced frequency bands. Thus, they inherently 
quantify the filtering effects of the vocal tract (if we consider 
the conceptually appealing source-filter voice production 




detect subtle changes in the position and motion of the 
articulators (tongue, lips) which are known to be affected in 
PD [13]. 
Overall, we applied 132 dysphonia measures to the speech 
database, each dysphonia measure producing a single real 
value per voice sample, resulting in a design matrix of size 
4010×132 for male PWP and a matrix of size 1865×132 for 
female PWP. 
Feature selection 
The use of a large number of features (132 in this study) 
makes it extremely difficult to discern meaningful patterns 
in the data, and may often be detrimental in the process of 
mapping the features onto the clinical outcome UPDRS. This 
problem is known as the curse of dimensionality, and arises 
because adequate population of the feature space requires 
that the number of voice samples increases exponentially 
with the number of features [49]. Contemporary algorithms 
that can map features onto outcomes may be very robust to 
the inclusion of potentially noisy or irrelevant features, and 
their predictive power may or may not be severely affected; 
however, a smaller feature set always facilitates insight into 
the problem by allowing interpretation of the most predictive 
features [50], [51]. An exhaustive search through all possible 
feature subset combinations is computationally impractical; 
feature selection (FS) algorithms are a principled approach 
to selecting a smaller (lower dimensional) feature subset. We 
refer to Guyon et al. [51] for a detailed overview of FS. 
Here, we compared four FS algorithms: (1) Least Absolute 
Shrinkage and Selection Operator (LASSO) [52], (2) 
Minimum Redundancy Maximum Relevance (mRMR) [53], 
(3) RELIEF [54], and (4) feature importance in Random 
Forests (RF) [55]. We applied the FS voting strategy that was 
previously described in Tsanas et al. [35], [48], [56] to 
identify the final feature subset 𝑆 for each FS algorithm, 
which was used in the subsequent statistical mapping phase. 
We refer readers to section 1.2 ‘Background on feature 
selection’ of the Supplementary Material for further 
background on FS and the FS voting strategy.  
Feature mapping 
In the preceding steps we have computed 132 
characteristic patterns from the sustained vowel phonations, 
and subsequently applied FS techniques to obtain subsets of 
those features. Here, we aim to determine the functional 
relationship 𝑓(𝐗) = 𝐲, which maps the dysphonia measures 
𝐗 = (𝐱1 … 𝐱𝑀), where M is the number of features, to the 
outcome (response) y (motor-UPDRS and total-UPDRS in 
this study). That is, we want to obtain a classifier that will 
use the dysphonia measures to accurately predict UPDRS. 
There is a large literature on supervised classification, and 
we refer to Bishop [49], and Hastie et al. [50] for a broad 
overview of this area. Here, we experimented with three 
powerful classifiers: Random Forests (RF), Support Vector 
Machines (SVM), and eXtreme Gradient Boosting 
(XGBoost). For more specific background on these 
statistical learners please see section 1.3 ‘Background on 
statistical learners’ in the Supplementary Material. 
Model validation and generalization 
As in previous studies [9], [24], [26] we used 10-fold 
Cross Validation (CV) to assess the generalization 
performance of the statistical learners. Conceptually, CV 
provides an estimate of the accuracy with which UPDRS 
may be predicted on a new dataset, assuming the new dataset 
has similar statistical characteristics to the data used to train 
the classifier. Specifically, we split the initial dataset 
comprising 𝑁 (4010 for males and 1865 for females) 
phonations into a training (in sample) subset of 0.9 ∙ 𝑁 (3609 
and 1679) phonations and a testing (out of sample) subset of 
0.1 ∙ 𝑁 (401 and 186) phonations. For statistical confidence, 
the process was repeated a total of 100 times, randomly 
permuting the data each time before splitting into training 
and testing subsets. As in previous studies [9], [24], [25], 
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 (1) 
where ?̂?𝑖  is the predicted UPDRS and 𝑦𝑖  is the actual UPDRS 
for the ith entry in the training or testing subset, 𝑁 is the 
number of phonations in the training or testing subset, and Q 
contains the indices of that set. Errors over the 100 CV 
iterations were averaged. We also computed the Confidence 
Interval (CI) of the errors (using 95% confidence level). 
Finally, we also trained and assessed the model 
performance by using a validation scheme leaving samples 
out from a participant. Specifically, the data from the L-1 
participants (where L is the total number of subjects, 28 
males and 14 females for the models we build, respectively), 
the data from the first four weeks of the left-out participant 
were used for training, and the model performance was 
reported for the remaining five months. In addition to the 
dysphonia measures we presented RF with the UPDRS 
values during the first four weeks for the left-out participant 
(this would be known in practical setting in this tracking 
scenario and is implicitly a calibration approach). This model 
validation approach replicates the tracking setting where past 
data from the same subject in addition to the database built 
from the remaining L-1 participants are used to replicate 
future UPDRS scores for each of the participants. Errors for 
the weekly UPDRS scores were averaged. We did not 
include timing information, participants’ age, or participant 
identifiers as inputs into the statistical learners in order not 
to implicitly bias the statistical learning models. 
IV. RESULTS 
Prior to any analysis, it is useful to visually appreciate the 
variability of UPDRS within participants. Fig. 2 presents 
violin plots with the total-UPDRS variability for each 
participant in the study, stratifying the data by sex. We 
clarify that we used all weekly UPDRS estimates derived 
using linear interpolation to present here (rather only the 
three UPDRS clinical assessments per participant) because 
these are subsequently used as the ground truth for training 




participants the UPDRS range is over 10 points (7.67 ± 4.12 
for males and 9.69 ± 4.22 for females). We computed 
Spearman correlation coefficients to quantify the strength of 
statistical association of the features with UPDRS, and 
compared these new association strengths to our previous 
findings [9] (see Tables I and II for comparisons of the 
correlation coefficients of indicative features with UPDRS 
for males and females, respectively). The results in these two 
tables illustrate the changes in the univariate statistical 
association of the features with UPDRS and implicitly 
demonstrate the effect the noise and the data transmission 
channel have in terms of using speech signals to replicate PD 
symptom severity. As expected, in most cases there are 
stronger statistical associations with the raw data; there are a 
few cases where the magnitude of the correlation coefficients 
appears slightly larger in the noisy data which can be 
attributed to statistical fluctuations. We have found that, as 
expected, the features in the present study had lower 
association strength with motor-UPDRS and total-UPDRS 
than in earlier studies that used full bandwidth speech [9]. 
Fig. 3 provides a succinct representation of the univariate 
association of each feature with total-UPDRS. Overall, 
univariate associations appear to be stronger for females, 
particularly for features which focus on F0 (jitter, GQ, F0-
related features). We report the out-of-sample accuracy 
(using RF) with which UPDRS can be predicted in 
Supplementary Material Table 1 for males, and 
Supplementary Material Table 2 for females. For each FS 
algorithm, the final number of features 𝐾 is determined using 





Fig. 2.  Violin plots with the total-UPDRS variability within each of the 
28 male participants and 14 female participants in the study. The white 
dot in each violin indicates the median, the grey box represents the range 
for the 25th percentile (bottom) and 75th percentile (top) entries. The 




CORRELATION COEFFICIENTS OF FEATURES WITH TOTAL UPDRS IN 
FEMALES  (EXTRACTED FROM THE RAW DATA AND FROM THE NOISY DATA) 
Feature name 
Spearman correlation coefficient R 
Raw data Noisy data 
Jitter (abs 0th perturbation) 0.38 0.34 
Shimmer (abs differences) 0.33 0.25 
HNR -0.44 -0.44 
GNENSR,TKEO 0.12 0.12 
DFA -0.02 0.07 
PPE 0.40 0.39 
VFERSNR,SEO -0.18 -0.07 
Log energy -0.49 -0.53 
12th MFCC 0.26 0.04 
Std F0 0.32 0.31 
In all cases the features were statistically significantly (p<0.05) correlated 
with UPDRS. We present one indicative feature from each algorithmic 
family of dysphonia measures. 
TABLE I 
CORRELATION COEFFICIENTS OF FEATURES WITH TOTAL UPDRS IN MALES  
(EXTRACTED FROM THE RAW DATA AND FROM THE NOISY DATA) 
Feature name 
Spearman correlation coefficient R 
Raw data Noisy data 
Jitter (abs 0th perturbation) 0.12 0.12 
Shimmer (abs differences) -0.14 -0.02 
HNR -0.02 0.05 
GNENSR,TKEO 0.11 0.10 
DFA -0.21 -0.10 
PPE 0.03 0.05 
VFERNSR,entropy 0.19 0.16 
Log energy 0.17 0.03 
6th MFCC -0.29 -0.15 
Std F0 0.15 0.18 
In all cases the features were statistically significantly (p<0.05) correlated 
with UPDRS. We present one indicative feature from each algorithmic 




parsimony, we fix 𝐾 to be the number of features where 
MAE is up to one standard deviation larger than the globally 
lowest MAE obtained with the feature subsets from that FS 
algorithm. The MAE for motor-UPDRS is 2.91 ± 0.23 
(CI=[2.49, 3.46]) for males and 2.38 ± 0.23 (CI=[2.19, 3.13]) 
for females, whilst the MAE for total-UPDRS is 3.43 ± 0.27 
(CI=[3.08, 4.11]) for males and 2.91 ± 0.27 (CI=[2.58, 3.54]) 
for females. The out-of-sample performances using SVMs 
and XGBoost are not presented because results were 
consistently worse compared to RF. 
The methodology was repeated contaminating the speech 
signals with AWGN or pink noise prior to speech coding and 
transmission. In both cases, the results were very similar 
(slight differences due to statistical fluctuation). By 
comparison, in a recent study in this application where high-
quality, high-bandwidth, uncompressed speech signals from 
the AHTD were used instead, the MAE reported for total-
UPDRS was [26]: 1.49 ± 0.14 for males, and 2.14 ± 0.25 for 
females. We defer further elaboration of those findings for 
the Discussion.  
Finally, for the model validation approach where we used 
the data from L-1 participants and only the first month of the 
data for each left-out participant to train the model and 
aiming to estimate their future total-UPDRS in the following 
5 months (UPDRS tracking), we obtained MAE 3.62 ± 2.25 
(CI=[2.83, 4.47]) for males and 4.74 ± 2.20 (CI=[3.67, 5.86]) 
for females.  
V. DISCUSSION 
We had previously demonstrated that using speech signals 
may be very promising in both (a) differentiating PD subjects 
from age- and gender-matched healthy controls [48], and (b) 
telemonitoring PD symptom severity by means of replicating 
the standard clinical scale UPDRS [9], [24], [25], [26]. In all 
those studies we had used high-quality speech signals, 
collected using high sampling frequency with minimal signal 
distortion (for example the signals were collected in a sound-
treated booth in [48]). In this study, we investigated the 
robustness of using lower quality signals which have been 
transmitted through the simulated GSM mobile telephone 
network. We found strong evidence that the existing GSM 
network, which to-date reaches more than 5 billion 
subscribers, enables clinically accurate UPDRS estimation. 
In Tsanas et al. [26], where the high-quality signals 
obtained from Intel’s AHTD were used, we reported that 
UPDRS could be estimated to within 1.5 UPDRS points for 
males and 2.2 UPDRS points for females; here we 
demonstrated that UPDRS can be estimated to within 
approximately 3.4 UPDRS points for males, and 2.9 UPDRS 
points for females (when comparing results against [26] 
where also 10-fold CV was used). We argue that this loss in 
accuracy of UPDRS, which is due to bandwidth restriction 
and/or channel transmission error is acceptable in practice 
because most PWP who could benefit from remote symptom 
tracking, are unlikely to have access to expensive, dedicated 
hardware such as the AHTD. We emphasize that the 
accuracy with which UPDRS is estimated even in this 
scenario of restricted quality speech, is less than the inter-
rater variability (difference in UPDRS score between two 
expert clinicians), which is about 4-5 points [57]. Putting our 
findings in the wider context: clinical colleagues had 
previously remarked that in their view our early 
investigations in 2010 towards replicating UPDRS using 
speech were insufficiently accurate to be widely deployed in 
clinical practice (the MAE in that study was 7.5 points) [24]. 
They had emphasized this technology would be practically 
very useful if we could demonstrate the MAE to be better 
than the inter-rater variability (i.e. less than 5 UPDRS 
points). This has been the informal threshold that we had 
used as guidance to deem whether our findings are 
practically ‘sufficiently good’. Therefore, speech over GSM 
remains clinically useful here, and could be used as a 
decision support tool to aid clinicians in remote, non-
invasive PD symptom severity assessment. Similarly, the 
automatic assessment of voice pathologies using signals 
transmitted over the public telephone network had been 
shown to be promising in related applications [28], [29].  
The topic of the appropriate methodology towards 
reporting out-of-sample performance is considerably more 
subtle than it first appears and has attracted some recent 
attention [58], [59]. The latter article contains discussion 
from three research groups weighing on the topic of how best 
to provide an estimate of generalization performance in 
clinical settings. We remark that the first guiding principle in 
deciding on the model validation scheme is how we envisage 
the deployed model will be subsequently used in practice 
(i.e. the intended usage should dictate the model validation 
approach). The argument is that standard CV may include 
confounding variables which could potentially overestimate 
performance because samples from the same subject end up 
in both the training and testing subsets [58]. In the debate 
appearing in [59] there is discussion and different opinions 
 
Fig. 3.  Visual representation of the feature correlations with total UPDRS. 
Features 1 to 30 are jitter variants, 31-51 shimmer variants, 51-60 HNR and 
GQ variants, 59-82 energy-related measures (RPDE, GNE, EMD-ER), 83-
124 MFCCs, 125-132 F0-related features.  
  











































on confounders and which approach should be used when 
aiming to develop a tool towards diagnosis. However, all 
three research teams essentially agree that standard leave-
subject-out methods underfit the data when it comes to 
tracking and endorse the use of validation methods where 
samples from the same subject are used in both training and 
testing sets. In particular, Varoquaux recommends only 
using samples from the subject’s past to estimate future 
entries in this tracking setting [59]. We emphasize that the 
problem investigated in this study comes under the broad 
area described as tracking in the studies above [58], [59]. 
Motivated by these points, we have introduced a model 
validation approach where we used data from the first 4 
weeks of a participant in the training set (in addition to the 
data from all other L-1 participants), and tested the 
performance on the remaining five months for the left-out 
participant. We demonstrated that also in this case we have 
relatively accurate results (MAE for total-UPDRS is 3.72 ± 
2.29 for males and 4.86 ± 2.42 for females). The MAE is 
lower in males, likely reflecting the lower average individual 
UPDRS variability observed in Fig. 2. From a practical 
perspective, this model validation approach we used here is 
directly comparable to a tracking paradigm that records some 
phonations and obtains the UPDRS clinical assessments by 
an expert neurologist for a specific participant before 
deploying the tool for longer-term UPDRS tracking. 
In a related earlier study, Bayestehtashk et al. enrolled 168 
PD participants and focused on replicating motor-UPDRS 
using sustained vowels /ah/, a diadochokinetic task, and a 
reading task (using standardized, linguistically rich text) 
[60]. They reported a MAE of 5.5 motor-UPDRS points. To 
the best of our knowledge, this is the only study by a different 
research group that used speech to replicate symptom 
severity as expressed using UPDRS and quantitatively 
expressed performance using some error metric.   
Concurring with previous findings, we have found that a 
parsimonious speech feature subset actually improves the 
out-of-sample MAE, and is also more amenable to 
interpretation [9], [24], [26]. We experimented with different 
statistical learners aiming to improve the out of sample 
performance. In addition to RF, we explored SVMs (linear 
SVM, polynomial SVM), and XGBoost (both in regression 
and classification mode), exploring different configurations 
and optimization of their internal hyper-parameters (results 
not shown). The radial basis function SVM was considerably 
better than linear SVM and generally better than the 
polynomial SVM. RF outperformed SVMs and XGBoost 
consistently and significantly (p<0.001), although we cannot 
provide a clear theoretical justification for this finding. More 
detailed empirical and theoretical analysis is required to 
understand which classification algorithm is likely to lead to 
more accurate prediction for similar datasets [35]. 
The UPDRS scores used as the response variable in our 
investigations have different class membership, i.e. this is an 
unbalanced multi-class classification statistical learning 
setting, which is known to be challenging in practice. There 
are different strategies to cope with the class unbalance 
problem including (a) using different weights internally in 
the classifier for the samples belonging to different classes 
(as a function of sample domination in the training data in 
each iteration, where under-represented classes are up-
weighted), and (b) using different probabilistic cut-offs for 
the different classes (again, these can be set to be inversely 
proportional to class dominance). We stress that these 
adaptive thresholds should only use information from the 
training dataset (similarly, in a CV application these need to 
be recomputed accordingly using only the information 
available in the training of the classifier). We have explored 
both approaches to train different RF models, however 
neither led to improving the out of sample performance 
(detailed results not shown). There is a more sophisticated 
approach to tackle class unbalance in statistical learning, by 
generating new (artificial) data points, e.g. using techniques 
such as the Synthetic Minority Over-sampling Technique 
(SMOTE) [61] and Adaptive Synthetic Sampling 
(ADASYN) [62]. Then, we can explore using the augmented 
dataset (comprising both the original and artificial data)  in 
the statistical learning process. Again, there are different 
strategies within data generation, e.g. to ensure all classes 
have equal membership (completely balanced dataset), or 
ensuring there is no clear dominance of particular class(es) 
in order not to contaminate the data with a very large number 
of artificial samples. We had not explored these data 
generation approaches here because it would diverge from 
the main focus of the study, however it would be an 
interesting direction to pursue in further work. 
We used four FS algorithms and applied a voting 
mechanism approach across perturbed versions of the dataset 
(see Supplementary Material for details, including the 
discussion therein on FS strategies) to identify features 
which are jointly most predictive of UPDRS. The use of 
perturbed versions of the data enables the investigation of 
consistency within each FS algorithm, and the use of 
different FS algorithms provides insight into FS consistency 
across FS algorithms. The non-classical dysphonia measures 
(mainly IMFNSR,SEO, VFER) and MFCCs are consistently 
selected as the most predictive features by RELIEF and RF 
feature importance (which appear to lead to the lowest MAE, 
see Supplementary Material Tables 1 and 2). The selection 
of MFCCs is very consistent across all FS algorithms. These 
results reinforce previous findings suggesting that dysphonia 
measures focusing on energy aspects may be promising for 
vocal pathology assessment [35], [48]. Similarly to previous 
studies [9], [26], [35], the features selected are gender-
dependent and focus on different pathological effects in 
PWP’s voice. This finding supports the tentative 
physiological suggestion that the underlying processes of 
degradation in PD speech may be different in men and 
women [9], [35]. For females the selected features are mainly 
log energy, low MFCCs and F0 related measures; for males 
they are DFA, IMFSNR,SEO, VFERNSR,entropy, and mid-range 
MFCCs. Overall, the most promising characteristic in PD 
speech pathology for males appears to be working with 




turbulent noise (DFA), excitation of different frequency 
bands and turbulent noise in vocal fold cycles (VFER), and 
ratio of high frequency (>2.5 kHz, denoting ‘noise’ in the 
signal) over low frequency (<2.5 kHz) energy (IMF). For 
females, the most promising characteristic in PD speech 
pathology appears to be the signal energy (log energy, 0th 
MFCC). Interestingly, some dysphonia measures that rely on 
F0 may also provide clinical information for females but not 
for males. As we argued previously [9], [35], this finding 
may be because natural male voices have considerably more 
vibrato (physiological tremor) compared to female voices. 
Given that females have higher F0 on average [27], and that 
higher F0 is normally associated with lower F0 variability 
[42], F0 perturbations might reflect voice pathology in 
females whilst similar distortions in males’ vocal 
performance could be, at least partly, attributed to normal 
vibrato. This is likely the same underlying reason why log 
energy is very strongly associated with UPDRS in females 
(R=-0.53) but poorly associated with UPDRS in males: log 
energy captures the main ‘power’ in the signal which is 
primarily driven by the contribution of the lungs and vocal 
folds (as the source of the recorded signal, considering the 
basic source-filter model of the vocal production mechanism 
[27]). It is possible that the vocal folds in PD might be more 
strongly affected in females compared to males, and also 
normal vibrato in males might be masking underlying F0 
perturbations (which in female voices may more clearly 
indicate underlying pathology) [35]. Incidentally, the 
negative correlation of log energy with UPDRS verifies what 
is intuitively expected: reduced log energy corresponds to 
reduced loudness (which is well reported in PD [13]) and 
may be used as a marker of symptom severity. 
MFCCs have been widely used in speech applications and 
have been previously shown to perform very well in related 
biomedical applications, e.g. [47]. This study further 
supports their use as powerful features in PD monitoring, as 
evidenced in the FS findings reported in Supplementary 
Material Tables 1 and 2. Although MFCCs are well-founded 
from a speech signal processing perspective, their 
physiological interpretation is more challenging. The lower 
MFCCs reflect the amplitude and envelope spectral 
fluctuations, and higher MFCCs convey mainly information 
about harmonic components; mid-range MFCCs are not 
easily interpretable. 
We had previously reported that the VFER family of 
dysphonia measures is amongst the best approaches to 
quantify information in speech signals to estimate UPDRS 
for males [35], [9]. Although VFER measures were still 
selected here by all FS algorithms, they do not appear near 
the top of RELIEF and RF feature importance. This may be 
because VFER relies on quantifying the information in the 
high frequencies (>2.5 kHz) as ‘noise’; however due to the 
reduced bandwidth when using a sampling rate of 8 kHz 
much of this high-frequency information is lost. This would 
suggest that the effectiveness of VFER relies on using high 
sampling rates (>20 kHz), in order to accurately quantify the 
extent of high frequency noise in the signal. In general, 
young adult pathology-free voices may be harmonically 
efficient up to about 6 kHz; therefore the suggested threshold 
of 2.5 kHz for denoting ‘noise’ may require further 
clarification. This empirical finding was reported in Tsanas 
et al. [9], considering frequencies below 2.5 kHz to denote 
‘signal’ and frequencies above 2.5 kHz to denote ‘noise’: the 
threshold was optimized scanning frequencies (using steps 
of 500 Hz similarly to Michaelis et al. [45]) in order to 
determine UPDRS. Interestingly, broadly similar findings 
regarding the threshold of ‘signal’ and ‘noise’ have been 
described by other research groups. For example, Gomez-
Vilda et al. [63] indicated that frequencies above 2 kHz can 
be generally considered turbulent noise. Likewise, the Multi-
Dimensional Voice Program (MDVP - 
http://www.kayelemetrics.com/) program includes “Voice 
Turbulence Index”, which is an alternative dysphonia 
measure relying on the SNR concept, where the spectral 
energy above 2.8 kHz is used to denote the high frequency 
energy component in the speech signal [64]. Overall, we 
tentatively suggest that the empirical 2.5 kHz threshold may 
have a solid physiological justification which is reflected 
broadly in the findings of different researchers: most of the 
energy in the sustained vowels is up to the second formant, 
and the second formant can be up to about 1.7 kHz for the 
sustained vowel /ah:/ [27].  
One very interesting new finding in this study is that 
UPDRS estimation in males deteriorates considerably more 
compared to UPDRS estimation in females as a result of the 
lower quality speech signals. This may be related to the 
bandwidth restriction, but may also be a consequence of the 
finite bit allocation available to reproducing the pitch period 
with pitch pulses. It could also be due to the increased noise 
that is masked by the formants in the perceptually-weighted 
linear prediction: this noise may not be heard, but may, 
nonetheless, be important in PD. 
The future of health telemonitoring is linked to the 
potential of smartphones and associated apps. A promising 
development in that direction would be the deployment of a 
smartphone app that can record high-quality (wide-band and 
low-distortion) speech signals. This further underlines the 
generalization potential of using speech signals towards 
future PD symptom monitoring systems. Nevertheless, there 
are still many people (particularly elderly, who are the main 
beneficiaries of the proposed technology) that do not own or 
do not know how to operate a smartphone. Although it is 
conceivable this might change in the next 10-20 years as 
smartphones are becoming more affordable and the current 
generation of 50-60 year-old people are generally better 
adapted to the use of smartphones, we envisage the proposed 
technology here with standard mobile telephony may remain 
pertinent because of its simplicity in use. 
Our findings confirm the established view in the clinical 
speech community suggesting that speech signals of at least 
20 kHz should be preferred in clinical applications because 
there is useful information in the higher frequencies of the 
spectrum [27]. Nevertheless, the performance degradation as 




communication framework is unlikely to be prohibitive for 
clinically useful UPDRS prediction. We conjecture that this 
may also be the case for other voice pathologies. We 
hypothesize that the speech community may have, hitherto, 
been overly pessimistic in the need for very high-quality 
speech signals [27] in clinical speech science. 
We stress that the results reported in this study were 
obtained in a simulated digital communications framework 
involving the GSM standard. Additional tests in real-world 
contexts using actual mobile phones would be required to 
validate the robustness of the presented methodology. For 
example, in practice the channel may or may not always 
introduce additive white Gaussian noise, although this is 
generally the assumption in the digital communication 
literature [40], [41]. Also, we have not simulated the effect 
of drop-outs due to cell handoff, or switching between 
2G/3G, or quality reduction due to the user not placing the 
phone close to their mouth. For this reason, our channel is 
chosen to be extremely noisy which introduces quite severe 
speech signal quality degradation. Additional factors that are 
hard to control, such as the mobile phone’s microphone, 
might need to be taken into account in a real application. 
Ideally, the microphone should exhibit uniform frequency 
response over the frequencies of interest (50 Hz – 10 kHz) to 
minimize spectral distortion. Similarly, microphones with 
reasonable SNR (>50 dB) may be required to ensure 
sufficient recording quality. Most commercially available 
microphones embedded in mobile phones adhere to these 
requirements. A detailed comparison of different 
microphones would reveal the extent to which speech signals 
are affected, and whether additional processing is necessary 
for signals recorded using mobile phones. Similarly, we have 
not pursued a full-scale simulation of different SNR and 
communication channels because this would involve 
reporting error rates and repeating the entire process with 
feature extraction, selection, and statistical mapping for 
different simulation scenarios. Instead we chose a moderate 
SNR (10dB) and a particularly hostile environment with the 
Proakis C channel which is frequently used in the literature 
to assess the performance of simulated digital 
communication approaches [40]. Therefore, we are 
reasonably confident that this study reports findings on a 
very challenging simulated digital communications 
environment. 
It is not straightforward to test the proposed methodology 
in practice: this would involve building the receiver block 
and ideally testing (a) several types of commercially 
available microphones and analogue-to-digital conversion 
hardware, and also (b) the reception of signals in various 
realistic scenarios (e.g. in a rural, urban, or hilly 
environment), which would probably introduce additional 
distortion to the transmitted signal. Other scenarios to test 
include cell handover. Development engineers would need 
to test the proposed methodology in such diverse practical 
settings in future work. As we reported recently through a 
systematic review, there are relatively few paradigms where 
research findings are translated into digital health 
interventions to benefit patients [65]. The promising findings 
presented in this study and the reported results by other 
colleagues provide compelling evidence to suggest this is a 
sufficiently mature field to merit detailed testing in a new 
study that will explore all these different practical 
challenges. 
The research area of speech signal processing and PD has 
generated considerable interest in the scientific community 
in the last 10-15 years and has led to some recent exciting 
developments. For example, there has been consistent 
interest in the binary differentiation of PD from healthy 
controls [48], [66], [67] amongst different research teams, 
which has generally led to very successful outcomes. We 
have recently reported on our findings in the Parkinson’s 
Voice Initiative (PVI), a large international study where we 
had collected more than 19,000 sustained vowel /a/ 
phonations across seven countries [30]. The PVI phonations 
were collected under acoustically non-controlled conditions 
over the phone with the explicit aim of investigating large 
scale population screening towards PD assessment using 
telephone-quality speech. We had demonstrated clinically 
meaningful differentiation of PWP versus controls, thus 
highlighting the potential of this technology at scale. 
Recently, researchers have started exploring speech data 
from different corpora which may lead to new insights across 
PD populations with different linguistic backgrounds [30], 
[68]. Furthermore, some studies have investigated different 
speech tasks for PD evaluations [60], [68], although it is still 
early to decide whether any particular task is clearly better 
that competing approaches. Another area of recent interest is 
in terms of associating acoustic features with clinical 
interventions, e.g. with pharmacological treatment (L-dopa) 
[69] and deep brain stimulation [70]. Collectively, these 
studies highlight the enormous potential of speech signal 
analysis in diverse PD areas. Moreover, we are currently 
collecting longitudinal data (including speech) from a large 
number of people at risk of PD, aiming to retrospectively 
revisit data from those people who are subsequently 
clinically diagnosed with PD. This would help us potentially 
develop a tool towards PD prognosis. 
Telemonitoring in healthcare has received considerable 
attention lately, but global adoption is always constrained by 
the prohibitive costs associated with specialized 
telemonitoring hardware or equipment. Indicative recent 
explorative applications in the PD domain include the mPower 
study using iPhones to record a series of motor and cognitive 
tasks [71], and other studies relying on the capabilities of 
smartphones [72], [73], and wearables [74], which are not 
necessarily affordable and accessible to elderly PD patients 
leaving in rural areas. The exploration of highly cost-effective 
solutions, such as exploitation of existing cellular or PSTN 
telephone networks investigated in this study may be a critical 
step towards more widespread diffusion of this promising 
technology. We envisage the results of this study being a first 
step towards practical, affordable, and accurate telemonitoring 
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